Based on this mechanistic information, we identified a small chemical inhibitor which blocked the TBC1D15–NOTCH/NICD interaction and successfully used it to prevent HCC growth in the PDX in vivo model. This evidence concerns the gene TBC1D15 and hepatocellular carcinoma.